Key Griffith University research projects have received $4.5 million in funding from the National Health and Medical Research Council. Announced on December 15 by the Federal Minister for Health, The Honorable Greg Hunt MP, the seven Ideas Grants projects will contribute to vital health and medical research. Deputy Vice Chancellor (Research) Professor Mario Pinto said […]
Griffith University’s Institute for Glycomics has been awarded $2.66 million in Ideas Grant funding from the National Health and Medical Research Council (NHMRC) to aid four vital research projects. Director Professor Mark von Itzstein AO was delighted with the grant awards and said they cemented the Institute’s reputation as a leading biomedical research institute. “Our […]
A new experimental drug to treat sepsis has now entered the next stage of clinical trials in patients in Australia after successfully completing Phase 1a trials in healthy volunteers, reports Griffith University’s Institute for Glycomics. The sepsis drug candidate, co-invented by researchers led by Professor Mark von Itzstein AO at the Institute for Glycomics and […]
An experimental Alzheimer's disease treatment is proving effective at treating some of the most persistent, life-threatening antibiotic-resistant bacteria.
Griffith University researchers have discovered a novel approach that could lead to the personalised design of anticancer drugs that resist metastasis (tumour spread) in triple-negative breast cancer. Traditional chemotherapy includes metal-based drugs like Cisplatin, commonly used to treat breast and ovarian cancers. However, many of these traditional chemotherapies have severe side effects and cancers treated […]
Griffith University’s Institute for Glycomics is joining forces with the Sanctuary Cove precinct this October in a community partnership to raise funds to support vital breast cancer research. The Institute for Glycomics is home to the Australian Centre for Cancer Glycomics (A2CG), a unique national resource dedicated to cancer glycomics research. “Our unique research approach […]
A research project by Griffith University’s Institute for Glycomics seeks to identify and develop new drugs and a vaccine to protect against antibiotic-resistant gonorrhoea. The bacteria Neisseria gonorrhoeae (Ng) causes the sexually transmitted infection gonorrhoea, which has significant impact on global health, infecting more than 100 million people each year. “In 2018, ‘super gonorrhoea’, resistant […]